Lignans from Carthamus tinctorius suppress tryptophan breakdown via indoleamine 2,3-dioxygenase

Phytomedicine

Volumn 20, Issue 13, 2013, Pages 1190-1195

  Kuehnl, Susanne ^a   Schroecksnadel, Sebastian ^b   Temml, Veronika ^a   Gostner, Johanna M ^b   Schennach, Harald ^c   Schuster, Daniela ^a   Schwaiger, Stefan ^a   Rollinger, Judith M ^a   Fuchs, Dietmar ^b   Stuppner, Hermann ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Asteraceae; Carthamus tinctorius; Indoleamine 2,3 Dioxygenase; Neopterin; Safflower

Indexed keywords

ANTIDEPRESSANT AGENT; ARCTIGENIN; INDOLEAMINE 2,3 DIOXYGENASE; LIGNAN DERIVATIVE; MATAIRESINOL; NEOPTERIN; TRACHELOGENIN; TRYPTOPHAN;

ARTICLE; DRUG EFFECT; DRUG ISOLATION; IN VITRO STUDY; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; SAFFLOWER;

ASTERACEAE; CARTHAMUS TINCTORIUS;

ASTERACEAE; CARTHAMUS TINCTORIUS; INDOLEAMINE 2,3-DIOXYGENASE; NEOPTERIN; SAFFLOWER;

4-BUTYROLACTONE; CARTHAMUS TINCTORIUS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FURANS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LEUKOCYTES, MONONUCLEAR; LIGNANS; MOLECULAR STRUCTURE; NEOPTERIN; PLANT EXTRACTS; PLANTS, MEDICINAL; SEEDS; TRYPTOPHAN;

EID: 84884211071     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2013.06.006     Document Type: Article

References (29)

1. S.J. Bae, S.M. Shim, Y.J. Park, J.Y. Lee, E.J. Chang, and S.W. Choi Cytotoxicity of phenolic compounds isolated from seeds of safflower (Carthamus tinctorius L.) on cancer cell lines Food Science and Biotechnology 11 2002 140 146
2. I. Boldizsar, M. Kraszni, F. Toth, B. Noszal, and I. Molnar-Perl Complementary fragmentation pattern analysis by gas chromatography-mass spectrometry and liquid chromatography tandem mass spectrometry confirmed the precious lignan content of Cirsium weeds Journal of Chromatography A 1217 2010 6281 6289
3. F. von Bruchhausen Carthamus tinctorius L 6th ed. W. Blaschek, S. Ebel, E. Hackenthal, U. Holzgrabe, K. Keller, J. Reichling, V. Schulz, Hagers Enzyklopädie der Arzneistoffe und Drogen (4) vol. 3 2007 Wissenschaftliche Verlagsgesellschaft mbH Stuttgart 880 883
4. G.I. Byrne, L.K. Lehmann, J.G. Kirschbaum, E.C. Borden, C.M. Lee, and R.R. Brown Induction of tryptophan degradation in vitro and in vivo, a gamma-interferon-stimulated activity Journal of Interferon & Cytokine Research 6 1986 389 396
5. W. Chen, X. Liang, A.J. Peterson, D.H. Munn, and B.R. Blazar The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive t regulatory cell generation Journal of Immunology 181 2008 5396 5404
6. Y. Chen, and G.J. Guillemin Kynurenine pathway metabolites in humans, disease and healthy states International Journal of Tryptophan Research 2 2009 1 19
7. T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships, the combined effects of multiple drugs or enzyme inhibitors Advances in Enzyme Regulation 22 1984 27 55
8. European Pharmacopeia, 6.ed., 4. addendum 2008 Verlag Österreich GmbH Wien 6211
9. J. Fischer, A.J. Reynolds, L.A. Sharp, and M.S. Sherburn Radical carboxyarylation approach to lignans. Total synthesis of (-)-arctigenin, (-)-matairesinol, and related natural products Organic Letters 6 2004 1345 1348
10. D. Fuchs, A.A. Moeller, G. Reibnegger, E. Stoeckle, E.R. Werner, and H. Wachter Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms Journal of Acquired Immune Deficiency Syndromes 3 1990 873 876
11. E. Haroon, C.L. Raison, and A.H. Miller Psychoneuroimmunology meets neuropsychopharmacology, translational implications of the impact of inflammation on behavior Neuropsychopharmacology 37 2012 137 162
12. M. Jenny, E. Santer, E. Pirich, H. Schennach, and D. Fuchs Δ9-Tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro Journal of Neuroimmunology 207 2009 75 82
13. M. Jenny, M. Klieber, D. Zaknun, S. Schroecksnadel, K. Kurz, M. Ledochowski, H. Schennach, and D. Fuchs In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors Inflammation Research 60 2011 127 135
14. J.S. Jin, T. Tobo, M.H. Chung, C.M. Ma, and M. Hattori Transformation of trachelogenin, an aglycone of tracheloside from safflower seeds, to phytoestrogenic (-)-enterolactone by human intestinal bacteria Food Chemistry 134 2012 74 80
15. E.O. Kim, J.H. Oh, S.K. Lee, J.Y. Lee, and S.W. Choi Antioxidant properties and quantification of phenolic compounds from safflower (Carthamus tinctorius L.) seeds Food Science and Biotechnology 16 2007 71 77
16. A.J. Muller, J.B. DuHadaway, P.S. Donover, E. Sutanto-Ward, and G.C. Prendergast Inhibition of indoleamie 2,3-dioxygenase, an immunoregulatory target of the cancer supression gene Bin 1, potentiates cancer chemotherapy Nature Medicine 11 2005 312 319
17. E. Naik, and V.M. Dixit Mitochondrial reactive oxygen species drive proinflammatory cytokine production Journal of Experimental Medicine 208 2011 417 420
18. English ed. H. He, and L. Cui Pharmacopoeia of Peoples' Republic of China vol. 1 2010 China Medical Science and Technology Press Beijing 89 90
19. K. Schroecksnadel, B. Wirleitner, C. Winkler, and D. Fuchs Monitoring tryptophan metabolism in chronic immune activation Clinica Chimica Acta 364 2006 82 90
20. S. Schroecksnadel, M. Jenny, K. Kurz, A. Klein, M. Ledochowski, F. Ueberall, and D. Fuchs LPS-induced NF-kappaB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase Biochemical and Biophysical Research Communications 399 2010 642 646
21. H. Soliman, M. Mediavilla-Varela, and S. Antonia Indoleamine 2,3-dioxygenase, is it an immune supressor? Cancer Journal 16 2010 354 359
22. T.W. Stone Kynurenines in the CNS, from endogenous obscurity to therapeutic importance Progress in Neurobiology 64 2001 185 218
23. O. Takikawa Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated l-tryptophan metabolism Biochemical and Biophysical Research Communications 338 2005 12 19
24. G. Weiss, C. Murr, H. Zoller, M. Haun, B. Widner, C. Ludescher, and D. Fuchs Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells Clinical & Experimental Immunology 116 1999 435 440
25. B. Widner, E.R. Werner, H. Schennach, H. Wachter, and D. Fuchs Simultaneous measurement of serum tryptophan and kynurenine by HPLC Clinical Chemistry 43 1997 2424 2426
26. C. Winkler, B. Wirleitner, K. Schroecksnadel, H. Schennach, and D. Fuchs St. John's wort (Hypericum perforatum) counteracts cytokine-induced tryptophan catabolism in vitro Biological Chemistry 385 2004 1197 1202
27. C. Winkler, B. Wirleitner, K. Schroecksnadel, H. Schennach, E. Mur, and D. Fuchs In vitro effects of two extracts and two pure alkaloid preparations of Uncaria tomentosa on peripheral blood mononuclear cells Planta Medica 70 2004 205 210
28. B. Wirleitner, K. Schroecksnadel, C. Winkler, H. Schennach, and D. Fuchs Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro Immunology Letters 100 2005 159 163
29. G. Zhao, Y. Gai, W.J. Chu, G.W. Qin, and L.H. Guo A novel compound N(1) N(5)-(Z)-N(10)-(E)-tri-p-coumaroylspermidine isolated from Carthamus tinctorius L. and acting by serotonin transporter inhibition European Neuropsychopharmacology 19 2009 749 758